Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.410
0.00 (0.00%)
At close: Nov 20, 2024, 4:00 PM
2.400
-0.010 (-0.41%)
Pre-market: Nov 21, 2024, 6:11 AM EST
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of $474.85 million as of November 21, 2024. Its market cap has increased by 364.18% in one year.
Market Cap
474.85M
Enterprise Value
599.10M
1-Year Change
364.18%
Ranking
Category
Stock Price
$2.41
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from $204.10M to $474.85M, an increase of 132.66%. That is a compound annual growth rate of 7.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 474.90M | 39.68% |
| Dec 29, 2023 | 340.00M | -25.93% |
| Dec 30, 2022 | 459.00M | 215.68% |
| Dec 31, 2021 | 145.40M | -79.94% |
| Dec 31, 2020 | 724.80M | -55.52% |
| Dec 31, 2019 | 1.63B | 32.13% |
| Dec 31, 2018 | 1.23B | -28.50% |
| Dec 29, 2017 | 1.72B | 510.80% |
| Dec 30, 2016 | 282.40M | -43.67% |
| Dec 31, 2015 | 501.30M | -39.08% |
| Dec 31, 2014 | 822.90M | 290.00% |
| Dec 31, 2013 | 211.00M | 3.38% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| National Research | 433.60M |
| Xeris Biopharma Holdings | 432.34M |
| Pacific Biosciences of California | 429.97M |
| Quanterix | 429.08M |
| Foghorn Therapeutics | 428.62M |
| Aquestive Therapeutics | 423.07M |
| Revance Therapeutics | 418.56M |
| DocGo | 408.20M |